While the development of cell therapies today is largely focused on oncology indications, some companies, including Athersys, envision a future where these therapies could treat other diseases and conditions, such as cardiovascular disease. B.J. Lehmann, interim CEO of Athersys, spoke with ScienceBoard.net about a recent panel that he participated in at the Cell & Gene Meeting on […]

Boys with autism spectrum disorder who received 10 mg/kg of a suramin IV infusion known as PAX-101 experienced greater improvements in symptoms than those who received 20 mg/kg of the same treatment or placebo, data show. According to the CDC, one in 54 children in the U.S. had ASD in 2016, up from one in 150 children […]

Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases. In this interview CEO Dr. Murat Kalayoglu discusses the uniqueness of RNA cell therapy and its potential to completely eliminate cancer once and for all. Please describe the company’s story, mission, and goals. What sparked the […]